Mangoceuticals (MGRX) Stock: Buy, Sell, or Hold?
MGRX - Mangoceuticals, Inc. Common Stock
$0.44
-0.04 (-8.45%)
âŧ
5d:
-5.6%
30d:
+14.56%
90d:
+0.18%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When MGRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MGRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MGRX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MGRX is currently trading at $0.44, which is considered slightly high relative to its 30-day fair value range of $0.39 to $0.45.
Technical Outlook: Technically, MGRX is in a uptrend. Immediate support is located at $0.37, while resistance sits at $0.52. Short-term momentum is weak, with the stock down 8.4% recently.
Market Sentiment: MGRX scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MGRX is in a uptrend. Immediate support is located at $0.37, while resistance sits at $0.52. Short-term momentum is weak, with the stock down 8.4% recently.
Market Sentiment: MGRX scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.39 -
$0.45
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.4%
All Signals
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.4%)
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.39 -
$0.45
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$0.52
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Revenue Growth (YoY)
-59.1%
Share & Embed Analysis
Last updated: October 02, 2026 3:35 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 67 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 37 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 69 BUY |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 60 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 54 HOLD |
